Cas:49678-04-8 (2E)-3-(4-Bromophenyl)acrylaldehyde manufacturer & supplier

We serve Chemical Name:(2E)-3-(4-Bromophenyl)acrylaldehyde CAS:49678-04-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(2E)-3-(4-Bromophenyl)acrylaldehyde

Chemical Name:(2E)-3-(4-Bromophenyl)acrylaldehyde
CAS.NO:49678-04-8
Synonyms:2-Propenal, 3-(4-bromophenyl)-, (2E)-;4-Bromocinnamaldehyde;trans-3-(4-Bromophenyl)-2-propenal;(2E)-3-(4-Bromophenyl)acrylaldehyde;3-(4-bromophenyl)acrylaldehyde;trans-3-(4-Bromophenyl)acrolein;trans-3-(4-Bromophenyl)acrylaldehyde
Molecular Formula:C9H7BrO
Molecular Weight:211.055
HS Code:2913000090

Physical and Chemical Properties:
Melting point:78-82ºC
Boiling point:310.5±17.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.612
PSA:17.07000
Exact Mass:209.968018
LogP:3.01

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like 2-Propenal, 3-(4-bromophenyl)-, (2E)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,trans-3-(4-Bromophenyl)acrylaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,trans-3-(4-Bromophenyl)acrylaldehyde Use and application,4-Bromocinnamaldehyde technical grade,usp/ep/jp grade.


Related News: Some experts have criticised the ministry’s analysis because of possible bias that could be skewing the data. Others said Israel should wait a little longer to receive more information about the safety and effectiveness of a third shot. read more 6-[tert-butyl(dimethyl)silyl]oxyhexanoic acid manufacturers Last week, the health ministry estimated the vaccine was only 41% effective at halting symptomatic infections over the past month. Protection against severe disease remained strong at 91%. 8-Benzyl-1-thia-4,8-diazaspiro[4.5]decan-3-one suppliers With no new systemic lupus erythematosus treatments in over a decade, we’re working to make this new medicine available as soon as possible.” 2,3-dihydroxypropyl 3-sulfanylpropanoate vendor & factory.